Aarti Industries Ltd · NSE:AARTIIND
Aarti Industries — Q2 FY23 Earnings Presentation
21 slides from Aarti Industries's earnings presentation, Nov 15, 2022
Slide 1: Cover letter to stock exchanges
November 15, 2022 To, To, Listing/Compliance Department Listing/Compliance Department BSE LTD. National Stock Exchange of Phiroze Jeejeebhoy Towers, India Limited Dalal Street, “Exchange Plaza”, Plot No. C/1, Mumbai – 400 001. G Block Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051. CODE : 524208
Slide 2: Q2 FY23 Results Presentation
Focused Ready Q2 FY23 Results Presentation
Slide 3: Disclaimer
Disclaimer AARTI INDUSTRIES LIMITED may, from time to time, make written and oral forward looking statements, in addition to statements contained in the company's filings with BSE Limited [BSE] and National Stock Exchange of India Limited [NSE], and our reports to shareholders. The company does not
Slide 4: Agenda
Agenda 01 02 03 Company Q2 FY23 Growth Overview Financial Opportunity Results & Strategy 3
Slide 5: About Aarti Industries (AIL)
About Aarti Industries (AIL) Overview Leading Speciality Chemicals company in Benzene based derivatives with integrated operations and high level of cost optimization 150+ 1,100+ 60 15 Key value chains include Nitro Chloro Benzenes (NCBs), Di-Chloro Benzenes Products Domestic & Global Exporting
Slide 6: Robust R&D expertise
Robust R&D expertise 2 250+ 7 INR 100+ crore 40+ State-of-the-art R&D Engineers & scientists Patents filed R&D Spends in FY22; up Planned product centres across Maharashtra from Rs. 22 crore in FY17 introductions from R&D & Gujarat 18,000 sq. ft. 65+ Fully Digitised Paperless Focus on: Laboratory wi
Slide 7: Industries Served and Customer Profile
Industries Served and Customer Profile Key end user industries Key Customers Polymer and additives; agrochemicals and intermediates; dyes, pigments, paints, and printing inks; pharma intermediates, fuel additives, rubber chemicals, resins, etc. Industries Served Essentials (Agro, Pharma, FMCG) 50% 5
Slide 8: Key Strengths
Key Strengths Global Player in Top 3 In Chlorination and Alternate to China Nitration globally Well placed to Fully Backward Integrated Benzene based benefit from Low-cost, sustainable Derivatives with Industry Tailwinds manufacturing opportunities in Integrated Top 2 In Hydrogenation sunrise sector
Slide 9: Vision, Mission and Values
Vision, Mission and Values OUR VISION OUR VALUES To emerge as a ‘Global partner of choice’ for leading consume Excellence of specialty chemicals and We continuously intermediates raise the bar of our performance to delight our Integrity stakeholders. We practice highest ethical Care and moral Our co
Slide 10: Agenda
Agenda 01 02 03 Company Q2 FY23 Growth Overview Financial Opportunity Results & Strategy 9
Slide 11: Q2 & H1 FY23 – Financial Snapshot
Q2 & H1 FY23 – Financial Snapshot INR 1,847 29% INR 267 5% INR 150 crore INR 124 crore Q2 FY23 vs crore crore Q2 FY22 Revenues Revenues EBITDA Profit Before Tax Profit After Tax INR 3,603 23% H1 FY23 vs crore INR 548 crore INR 316 crore INR 260 crore H1 FY22 Revenues EBITDA Profit Before Tax Profit
Slide 12: Key Milestones/ Updates in H1 FY23
Key Milestones/ Updates in H1 FY23 • The proposed demerger for Pharma business undertaking INR 577+ cr. was approved by NCLT and thus the historic financials from CAPEX entailed the Appointed date i.e., 1st July 2021 were recasted to consider the effect of the scheme. • Increase in Export revenues a
Slide 13: Performance Overview – Q2 FY23
Performance Overview – Q2 FY23 Revenues of Rs. 1,847 crore; increase EBITDA of Rs. 267 crore; increase of PAT of Rs. 124 crore of 29% over previous year 5% over previous year. • Revenue growth was achieved on account of stable demand trajectory for the products under the essential end usages, and pr
Slide 14: Chairman’s Message
Chairman’s Message Commenting on the performance for Q2 FY23, Mr. Rajendra Gogri – Chairman & MD at Aarti Industries Limited said: “Q2 of the current fiscal year has been an eventful period for us. Not only have we delivered a stable financial performance, but also received NCLT approval to demerge
Slide 15: Q2 FY23 – Consolidated P&L
Q2 FY23 – Consolidated P&L Particulars (Rs. Crore) Q2 FY23 Q2 FY22 Y-o-Y (%) Q1 FY23 Q-o-Q (%) H1 FY23 H1 FY22 Y-o-Y (%) Gross Income from Operations 1,847 1,437 28.6% 1,755 5.2% 3,603 2,940 22.6% Exports 927 574 61.5% 778 19.2% 1,705 1,352 26.1% % of Total Income 50.3% 39.9% 44.2% 47.3% 46.0% EBITD
Slide 16: Q2 FY23 Highlights (Consolidated)
Q2 FY23 Highlights (Consolidated) Revenues EBITDA + 29% 1,847 + 5% 1,437 267 255 Q2 FY22 Q2 FY23 Q2 FY22 Q2 FY23 Interest Profit After Tax - 17% 150 - 300% 43 124 14 Q2 FY22 Q2 FY23 Q2 FY22 Q2 FY23 Amount in INR (Cr); 15
Slide 17: Agenda
Agenda 01 02 03 Company Q2 FY23 Growth Overview Financial Opportunity Results & Strategy 16
Slide 18: Future Growth Projects: FY23-24 (Driven by R&D & Innovation)
Future Growth Projects: FY23-24 (Driven by R&D & Innovation) Introducing Chloro Toulenes Value Key Highlights & Chain: (Range of products) Performance ● Adding new chemistries and Value added Setting up Newer range of products Universal Value Added products & o 40+ products for Chemicals Multipurpos
Slide 19: Major Projects: FY19 - FY23
Major Projects: FY19 - FY23 Operationalised by H1 FY23 To be Completed by H2 FY23 & FY24 Set up New Research & Operationalized Phase 1 Unit at Unit for 3rd Long Term Contract at Jhagadia Technology Centre at Navi Dahej SEZ for agrochemical Mumbai intermediates & Speciality Chemical NCB Capacity Expa
Slide 20: About Us
About Us Aarti Industries Limited (AIL) is one of the most competitive benzene-based speciality chemical companies in the world. AIL is a rare instance of a global speciality chemicals For further information please log on to company that combines process chemistry competence (recipe focus) with sca
Slide 21: Thank You
@ AARTI INDUSTRIES Growth Focused. UO Ready. Thank You